Products
Tropis
Stratis
Applications
Nucleic Acid Vaccines
COVID-19
Polio
Influenza
Resources
Press Coverage
News Releases
Publications
FAQs
Our Blogs
Events
About
About Pharmajet
Partnerships
Needle-free Technology
Contact
Publications
All Categories
Clinical Studies (5)
Pre-Clinical Studies (8)
All Tags
Adjuvants (1)
ANDV (3)
Arboviruses (10)
Atherosclerosis (1)
Cancer (3)
Clinical (2)
COVID-19 (8)
Cow (3)
Dengue (5)
DNA (24)
DOBV (1)
Equine Influenza (1)
Hamster (2)
Hantaviruses (5)
Hepatitis B (1)
HIV (1)
HNTV (1)
Horse (1)
HPV (1)
HTNV (1)
Improved Performance (13)
Inactivated (12)
Infectious Diseases (1)
Influenza (5)
Live Attenuated (7)
Lymphoma (1)
Mice (1)
MMR (3)
Mouse (2)
Nanoparticle (1)
Non-Human (1)
Non-Human Primate (10)
Other Applications (2)
Other Viruses (8)
Pentavalent (1)
Phase 1 (4)
Phase 1: Zika (1)
Phase 1/2 (2)
Phase 1/2: COVID-19 (1)
Phase 1b (1)
Phase 2 (2)
Phase 3/4 (1)
Phase 4 (3)
Phase III (1)
Pig (5)
Polio (9)
Pox (3)
Protein Subunit (2)
PRRSV (1)
PUUV (2)
Rabbit (4)
Rabies (1)
Respiratory Viruses (12)
RNA (2)
SEOV (1)
SNV (2)
Stratis (26)
Tropis (29)
Tropis/Stratis (6)
VEEV (2)
Zika (6)
Reset
A Hantavirus Pulmonary Syndrome (HPS) DNA Vaccine Delivered Using a Spring-powered Jet Injector Elicits a Potent Neutralizing Antibody Response in Rabbits and Nonhuman Primates
2014
Kwilas, S
Tags:
ANDV
,
DNA
,
Hantaviruses
,
Improved Performance
,
Non-Human Primate
,
Rabbit
,
SNV
,
Stratis
,
Tropis
,
Tropis/Stratis
View
«
1
2
Menu